Pazopanib Tablet, Film Coated
Product Images NDC 59651-582

This text provides data from a clinical study comparing the progression-free survival of patients treated with pazopanib (N=290) and placebo (N=145). The median progression-free survival was 9.2 months for pazopanib and 4.2 months for placebo. The hazard ratio was calculated as 0.46 with a 95% confidence interval of 0.34 to 0.62, indicating a significant difference between the two groups (P-value <0.001).*

This text provides data on the progression-free survival of patients in a clinical trial comparing Pazopanib (N=246) and Placebo (N=123) treatments. The median progression-free survival was 4.6 months for patients receiving Pazopanib and 1.6 months for those on Placebo. The Hazard Ratio was 0.35, with a 95% confidence interval of (0.26, 0.48) and a p-value less than 0.001, indicating a significant difference in progression-free survival between the two treatment groups.*

This is a label for Pazopanib Tablets with a prescription of 30 tablets. Each film-coated tablet contains 216.7g of pazopanib hydrochloride, equivalent to 200mg of pazopanib. The dosage information is provided separately. It should be stored at 20° to 25°C (68 to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medication guides can be printed from aurobindousa.com/medication-guides. Distributed by Aurobindo Pharma USA, Inc. *

This description is about a medication called Pazopanib in tablet form. Each film-coated tablet contains 216.7g of pazopanib hydrochloride, which is equivalent to 200mg of pazopanib. The tablets are distributed by Aurobindo Pharma USA, Inc. and made in India. The dosage information is available in the accompanying prescribing information. The tablets should be stored at controlled room temperature, and the pharmacist should dispense the Medication Guide provided separately to each patient. This product is for prescription use only and comes in a pack of 90 tablets with an NDC code of 59651-582-90. Additional information and Medication Guides can be found on the website aurobindousa.com/medication-guides.*

This is a description of Pazopanib tablets with NDC code 59651-582-08. Each film-coated tablet contains 200mg of pazopanib hydrochloride. The medication guide should be dispensed to each patient by the pharmacist. It is recommended to store the tablets at 20° to 25°C (68° to 77°F). The tablets should not be used if the safety seal under the cap is broken or missing. For more information, the prescribing information should be consulted. The tablets are distributed by Aurobindo Pharma USA, Inc. and are manufactured in India. Additional details can be found at www.aurobindousa.com/medication-guides. The drug is prescription-only and comes in a pack of 120 tablets.*